c-erbB-2 (HER-2/neu) gene amplification is a better indicator of poor prognosis than protein over-expression in operable breast-cancer patients

✍ Scribed by Guy Riou; Marie-Christine Mathieu; Michel Barrois; Marie-Luce Le Bihan; Jean-Charles Ahomadegbe; Jean Bénard; Monique G. Lê

• Publisher: John Wiley and Sons
• Year: 2001
• Tongue: French
• Weight: 144 KB
• Volume: 95
• Category: Article
• ISSN: 0020-7136
• DOI: 10.1002/1097-0215(20010720)95:4<266::aid-ijc1045>3.0.co;2-e